ArticleThe journal of headache and pain2026
Dorsal root ganglion neuromodulation restores accumbal gate to inhibit mechanical allodynia.
Article in The journal of headache and pain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMechanical allodynia refers to a hypersensitive status in response to innoxious stimuli caused by neuropathic pain. A therapeutic strategy to reverse the sensory impairment is neuromodulation treatment selectively targeting the dorsal root ganglion. However, the supra-spinal mechanism of neuromodulation therapy remains elusive.
methodsBy combination of the multiple-channel neurophysiology recording and cellular manipulation in freely moving rats, we investigated the gate function of nucleus accumbens in control of nociceptive inputs, and its role in pulsed-radiofrequency neuromodulation therapy for neuropathic pain, using a clinically relevant neuromodulation parameter.
resultsWe initially identified a gaining representation of the nucleus accumbens in response to nociceptive (pinprick), but not innoxious inputs (4 g Von Frey filament) in naïve rats. In neuropathic pain condition, the gate function was disrupted to drive an enhancement of accumbal activity during mechanical allodynia behavior. Pulsed radiofrequency neuromodulation of dorsal root ganglion was utilized to reverse pain hypersensitivity and accumbal homeostasis. Furthermore, we found that the accumbal gaining was not only a dynamic integration of painful signals, but also to serve as a gate of nociceptive perception required for neuromodulation therapy. In addition, the supra-spinal modulation effect on allodynic phenotype was imitated through optogenetic activation of the accumbal terminals of the spinal cord projections.
conclusionsOur data indicates that the accumbal gate is essential for integration and control of sensory inputs, potentially acting as one neuromodulatory target to reverse pain sensitization.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.